Cited by 1,924Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyAbdominal Surgery and Complications

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Open access

Russell, James A., Walley, Keith R., Singer, Joel, Gordon, Anthony C., Hébert, Paul C., Cooper, D. James, Holmes, Cheryl L., Mehta, Sangeeta, Granton, John T., Storms, Michelle M., Cook, Deborah J., Presneill, Jeffrey J., Ayers, Dieter·2008·New England Journal of Medicine

DOI 10.1056/nejmoa067373

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Vasopressin is commonly used as an adjunct to catecholamines to support blood pressure in refractory septic shock, but its effect on mortality is unknown. We hypothesized that low-dose vasopressin as compared with norepinephrine would decrease mortality among patients with septic shock who were being treated with conventional (catecholamine) vasopressors. METHODS: In this multicenter, randomized, double-blind trial, we assigned patients who had septic shock and were receiving a minimum of 5 microg of norepinephrine per minute to receive either low-dose vasopressin (0.01 to 0.03 U per minute) or norepinephrine (5 to 15 microg per minute) in addition to open-label vasopressors. All vasopressor infusions were titrated and tapered according to protocols to maintain a target blood pressure. The primary end point was the mortality rate 28 days after the start of infusions. RESULTS: A total of 778 patients underwent randomization, were infused with the study drug (396 patients received vasopressin, and 382 norepinephrine), and were included in the analysis. There was no significant difference between the vasopressin and norepinephrine groups in the 28-day mortality rate (35.4% and 39.3%, respectively; P=0.26) or in 90-day mortality (43.9% and 49.6%, respectively; P=0.11). There were no significant differences in the overall rates of serious adverse events (10.3% and 10.5%, respectively; P=1.00). In the prospectively defined stratum of less severe septic shock, the mortality rate was lower in the vasopressin group than in the norepinephrine group at 28 days (26.5% vs. 35.7%, P=0.05); in the stratum of more severe septic shock, there was no significant difference in 28-day mortality (44.0% and 42.5%, respectively; P=0.76). A test for heterogeneity between these two study strata was not significant (P=0.10). CONCLUSIONS: Low-dose vasopressin did not reduce mortality rates as compared with norepinephrine among patients with septic shock who were treated with catecholamine vasopressors. (Current Controlled Trials number, ISRCTN94845869 [controlled-trials.com].).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa067373

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

APACHE II
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
(1992) · Critical Care Medicine · doi:10.1097/00003246-199206000-00025 · Cited by 5,134
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,309
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,038
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310

Flagged first, then by citations

Show all 36 references

Research works printed but not linked: 2

Argenziano M, 1997, Circulation, 96, II
Chen JM, 1999, Circulation, 100, II

Sorted by citations

Items 201–300 of 999

Arginine vasopressin significantly increases the rate of successful organ procurement in potential donors
Plurad, D. S., Bricker, S. D., Neville, A. L., Bongard, F. S., & Putnam, B. A. (2012) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2012.05.011 · Cited by 89
Heparin-Binding Protein (HBP)
Fisher, J., Russell, J. A., Bentzer, P., Parsons, D., Secchia, S., Mörgelin, M., Walley, K. R., Boyd, J. H., & Linder, A. (2017) · Shock · doi:10.1097/shk.0000000000000862 · Cited by 90
Self-citation
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020)
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.659 · Cited by 88
β2-Adrenergic Receptor Gene Polymorphism Is Associated with Mortality in Septic Shock
Nakada, T., Russell, J. A., Boyd, J. H., Aguirre-Hernández, R., Thain, K. R., Thair, S. A., Nakada, E., McConechy, M. K., & Walley, K. R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0332oc · Cited by 88
Self-citation
Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units
Takahashi, W., Nakada, T., Yazaki, M., & Oda, S. (2016) · Shock · doi:10.1097/shk.0000000000000616 · Cited by 88
Randomized ICU Trials Do Not Demonstrate an Association Between Interventions That Reduce Delirium Duration and Short-Term Mortality
Al‐Qadheeb, N. S., Balk, E. M., Fraser, G. L., Skrobik, Y. K., Riker, R. R., Kress, J. P., Whitehead, S., & Devlin, J. W. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000224 · Cited by 87
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study
Rocco, M., Montini, L. M., Alessandri, E., Venditti, M., Laderchi, A., Gennaro, P. D., Raponi, G., Vitale, M., Pietropaoli, P., & Antonelli, M. M. (2013) · Critical Care · doi:10.1186/cc12853 · Cited by 87
Early recognition and management of sepsis in adults: the first six hours.
Gauer, R. L. (2013) · PubMed · Cited by 87
Intraoperative Hypotension and Acute Kidney Injury, Stroke, and Mortality during and outside Cardiopulmonary Bypass: A Retrospective Observational Cohort Study
de la Hoz, M. Á. A., Rangasamy, V., Bastos, A. B., Xu, X., Novack, V., Saugel, B., & Subramaniam, B. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004175 · Cited by 87
Sepsis subphenotypes, theragnostics and personalized sepsis care
Antcliffe, D. B., Burrell, A. J. C., Boyle, A. J., Gordon, A. C., McAuley, D. F., & Silversides, J. A. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-07873-6 · Cited by 99
Self-citation
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates
de Grooth, H.-J., Postema, J., Loer, S. A., Parienti, J.-J., Oudemans-van Straaten, H. M., & Girbes, A. R. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5134-8 · Cited by 92
Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series
Shah, P. R., Reynolds, P. S., Pal, N., Tang, D. G., McCarthy, H. L., & Spiess, B. D. (2017) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-017-1029-3 · Cited by 86
The journey to CAR T cell therapy: the pediatric and young adult experience with relapsed or refractory B-ALL
Hucks, G., & Rheingold, S. R. (2019) · Blood Cancer Journal · doi:10.1038/s41408-018-0164-6 · Cited by 87
Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock*
Roberts, R. J., Miano, T. A., Hammond, D. A., Patel, G. P., Chen, J., Phillips, K. M., Lopez, N. D., KASHANI, K. B., Qadir, N., Cairns, C. B., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004476 · Cited by 86
Optimal Vasopressin Initiation in Septic Shock
Kalimouttou, A., Kennedy, J. N., Feng, J., Singh, H., Saria, S., Angus, D. C., Seymour, C. W., & Pirracchio, R. (2025) · JAMA · doi:10.1001/jama.2025.3046 · Cited by 86
Persistent sepsis-induced hypotension without hyperlactatemia: Is it really septic shock?
Glenn Hernández, P., Castro, R., Romero, C. M., de la Hoz, C., Angulo, D., Aránguiz, I., Larrondo, J. F., Bujes, A., & Bruhn, A. R. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.09.007 · Cited by 86
Pediatric Basic and Advanced Life Support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations
Kleinman, M. E., de Caen, A. R., Chameides, L., Atkins, D. L., Berg, R. A., Berg, M. D., Bhanji, F., Biarent, D., Bingham, R., Coovadia, A. H., et al. (2010) · Pediatrics · doi:10.1542/peds.2010-2972a · Cited by 86
Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis
Patel, A., Waheed, U., & Brett, S. J. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2863-6 · Cited by 82
Sepsis and Septic Shock Strategies
Armstrong, B., Betzold, R., & May, A. K. (2017) · Surgical Clinics of North America · doi:10.1016/j.suc.2017.07.003 · Cited by 88
Vitamin C in sepsis
Kuhn, S.-O., Meissner, K., Mayes, L. M., & Bartels, K. (2018) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000549 · Cited by 82
Initial Emergency Department Diagnosis and Management of Adult Patients with Severe Sepsis and Septic Shock
Perman, S. M., Goyal, M. K., & Gaieski, D. F. (2012) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/1757-7241-20-41 · Cited by 87
Predictors of response to fixed-dose vasopressin in adult patients with septic shock
Sacha, G. L., Lam, S. W., Duggal, A., Torbic, H., Bass, S. N., Welch, S. C., Butler, R. S., & Bauer, S. R. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0379-5 · Cited by 84
Vasoplegic syndrome: An update on perioperative considerations
Liu, H., Yu, L. Z., Yang, L., & Green, M. S. (2017) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2017.04.017 · Cited by 82
Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis
Polito, A., Parisini, E., Ricci, Z., Picardo, S. G., & Annane, D. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2407-x · Cited by 81
The initial resuscitation of septic shock
Cinel, I., Kasapoglu, U. S., Gul, F., & Dellinger, R. P. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.02.004 · Cited by 69
Prevention and treatment of sepsis-induced acute kidney injury: an update
Honoré, P. M., Jacobs, R., Hendrickx, I., Bagshaw, S. M., Joannès-Boyau, O., Boer, W., Waele, E. D., Gorp, V. V., & Spapen, H. D. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0095-3 · Cited by 79
Tolerability of Enteral Nutrition in Mechanically Ventilated Patients With Septic Shock Who Require Vasopressors
Merchan, C., Altshuler, D., Aberle, C., Papadopoulos, J., & Schwartz, D. T. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616656799 · Cited by 85
Terlipressin versus other vasoactive drugs for hepatorenal syndrome
Israelsen, M. E., Krag, A. A., Allegretti, A. S., Jovani, M., Goldin, A. H., Winter, R. W., & Gluud, L. L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011532.pub2 · Cited by 79
Long-term mortality and quality of life after septic shock: a follow-up observational study
Nesseler, N., Defontaine, A., Launey, Y., Morçet, J., Mallédant, Y., & Séguin, P. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2815-1 · Cited by 79
Angiotensin II in Septic Shock
Corrêa, T. D., Jeger, V., Pereira, A. J., Takala, J. A., Djafarzadeh, S., & Jakob, S. M. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000397 · Cited by 79
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections
Sartelli, M., Viale, P., Koike, K., Pea, F., Tumietto, F., Goor, H. V., Guercioni, G., Nespoli, A., Tranà, C., Catena, F., et al. (2011) · World Journal of Emergency Surgery · doi:10.1186/1749-7922-6-2 · Cited by 79
Septic Shock — Evaluating Another Failed Treatment
Wenzel, R. P., & Edmond, M. B. (2012) · New England Journal of Medicine · doi:10.1056/nejme1203412 · Cited by 78
Early Management of Severe Sepsis
Marik, P. E. (2014) · CHEST Journal · doi:10.1378/chest.13-2104 · Cited by 79
Role of perioperative hypotension in postoperative acute kidney injury: a narrative review
Lankadeva, Y. R., May, C. N., Bellomo, R., & Evans, R. G. (2022) · British Journal of Anaesthesia · doi:10.1016/j.bja.2022.03.002 · Cited by 79
Precision management of acute kidney injury in the intensive care unit: current state of the art
Stanski, N. L., Rodrigues, C. E., Strader, M., Murray, P. T., Endre, Z. H., & Bagshaw, S. M. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07171-z · Cited by 79
Vasopressin and Its Immune Effects in Septic Shock
Russell, J. A., & Walley, K. R. (2010) · Journal of Innate Immunity · doi:10.1159/000318531 · Cited by 80
Self-citation
Low‐dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post‐cardiac surgery patients
Bragadottir, G., Redfors, B., Nygren, A., Sellgren, J., & Ricksten, S.-E. (2009) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2009.02037.x · Cited by 78
Vasopressors for hypotensive shock
Havel, C., Arrich, J., Losert, H., Gamper, G., Müllner, M., & Herkner, H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003709.pub3 · Cited by 78
Sepsis Diagnosis and Management
Gotur, D. B. (2017) · Journal of Medical Sciences and Health · doi:10.46347/jmsh.2017.v03i03.001 · Cited by 80
Sepsis and ARDS: The Dark Side of Histones
Xu, Z., Huang, Y., Mao, P., Zhang, J., & Li, Y. (2015) · Mediators of Inflammation · doi:10.1155/2015/205054 · Cited by 77
The intensive care medicine research agenda on septic shock
Perner, A., Gordon, A. C., Angus, D. C., Lamontagne, F., Machado, F. R., Russell, J. A., Timsit, J., Marshall, J. C., Myburgh, J., Shankar‐Hari, M., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4821-1 · Cited by 78
Self-citation
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐ SSCG 2016)
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Acute Medicine & Surgery · doi:10.1002/ams2.322 · Cited by 78
Severe sepsis and septic shock
Schorr, C., Zanotti, S. L., & Dellinger, R. P. (2013) · Virulence · doi:10.4161/viru.27409 · Cited by 78
A Selective V1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*
He, X., Su, F., Taccone, F. S., Laporte, R., Kjølbye, A. L., Zhang, J., Xie, K., Moussa, M. D., Reinheimer, T. M., & Vincent, J. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001380 · Cited by 75
Elevated Plasma Angiopoietin-2 Levels Are Associated With Fluid Overload, Organ Dysfunction, and Mortality in Human Septic Shock
Fisher, J., Douglas, J. J., Linder, A., Boyd, J. H., Walley, K. R., & Russell, J. A. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001853 · Cited by 77
Self-citation
PCSK9 at the crossroad of cholesterol metabolism and immune function during infections
Paciullo, F., Fallarino, F., Bianconi, V., Mannarino, M. R., Sahebkar, A., & Pirro, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25767 · Cited by 74
Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial
Wieruszewski, P. M., Bellomo, R., Busse, L. W., Ham, K. R., Zarbock, A., Khanna, A. K., Deane, A. M., Ostermann, M., Wunderink, R. G., Boldt, D. W., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04446-1 · Cited by 75
Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop
Harhay, M. O., Casey, J. D., Clément, M., Collins, S. P., Gayat, É., Gong, M. N., Jaber, S., Laterre, P., Marshall, J. C., Matthay, M. A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05934-6 · Cited by 79
Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial
Donnino, M. W., Andersen, L. W., Berg, K. M., Chase, M., Sherwin, R. L., Smithline, H. A., Carney, E., Ngo, L. H., Patel, P. V., Liu, X., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1257-x · Cited by 73
Vasopressor and Inotrope Therapy in Cardiac Critical Care
Jentzer, J. C., & Hollenberg, S. M. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620917630 · Cited by 77
Surviving sepsis: going beyond the guidelines
Marik, P. E. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-17 · Cited by 76
Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study)*
Póvoa, P. M. S. R., Carneiro, A., Ribeiro, O., & Costa‐Pereira, A. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181958b1c · Cited by 71
Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis
Masarwa, R., Paret, G., Perlman, A., Reif, S. S., Raccah, B. H., & Matok, I. (2017) · Critical Care · doi:10.1186/s13054-016-1589-6 · Cited by 73
Study Design and “Evidence” in Patient-oriented Research
Concato, J. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201303-0521oe · Cited by 74
Leucyl/Cystinyl Aminopeptidase Gene Variants in Septic Shock
Nakada, T., Russell, J. A., Wellman, H., Boyd, J. H., Nakada, E., Thain, K. R., Thair, S. A., Hirasawa, H., Oda, S., & Walley, K. R. (2011) · CHEST Journal · doi:10.1378/chest.10-2517 · Cited by 73
Self-citation
The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis*
Maybauer, M. O., Maybauer, D. M., Enkhbaatar, P., Laporte, R., Wiśniewska, H., Traber, L. D., Lin, C., Fan, J., Hawkins, H. K., Cox, R. A., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000300 · Cited by 69
A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension.
Hylands, M., Moller, M. H., Asfar, P., Toma, A., Frenette, A. J., Beaudoin, N., Belley-Côté, É., D’Aragon, F., Laake, J. H., Siemieniuk, R. A., et al. (2017) · Canadian Journal of Anesthesia/Journal canadien d'anesthésie · doi:10.1007/s12630-017-0877-1 · Cited by 69
Vasopressin Compared with Norepinephrine Augments the Decline of Plasma Cytokine Levels in Septic Shock
Russell, J. A., Fjell, C. D., Hsu, J. L., Lee, T., Boyd, J. H., Thair, S. A., Singer, J., Patterson, A. J., & Walley, K. R. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0355oc · Cited by 68
Self-citation
Treatment of Acute Kidney Injury: A Review of Current Approaches and Emerging Innovations
Tamargo, C. L., Hanouneh, M. A., & Cervantes, C. E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092455 · Cited by 81
“Less Is More” in Critically Ill Patients
Kox, M., & Pickkers, P. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.6702 · Cited by 68
Early goal-directed resuscitation of patients with septic shock: current evidence and future directions
Gupta, R. G., Hartigan, S., Kashiouris, M. G., Sessler, C. N., & Bearman, G. M. (2015) · Critical Care · doi:10.1186/s13054-015-1011-9 · Cited by 69
Hypotension within one-hour from starting CRRT is associated with in-hospital mortality
Shawwa, K., Kompotiatis, P., Jentzer, J. C., Wiley, B. M., Williams, A. W., Dillon, J. J., Albright, R. C., & KASHANI, K. B. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.07.004 · Cited by 66
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long‐term inhibition
Cesaro, A., Bianconi, V., Gragnano, F., Moscarella, E., Fimiani, F., Monda, E., Scudiero, O., Limongelli, G., Pirro, M., & Calabrò, P. (2020) · BioFactors · doi:10.1002/biof.1619 · Cited by 68
Prospective Open‐label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock
Hammond, D. A., Ficek, O. A., Painter, J. T., McCain, K., Cullen, J., Brotherton, A. L., Kakkera, K. S. S., Chopra, D., & Meena, N. K. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2105 · Cited by 66
Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign
Casserly, B. P., Gerlach, H., Phillips, G. S., Lemeshow, S. A., Marshall, J. C., Osborn, T. M., & Levy, M. M. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2720-z · Cited by 65
Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study
Timm, F. P., Houle, T. T., Grabitz, S. D., Lihn, A.-L., Stokholm, J. B., Eikermann‐Haerter, K., Nozari, A., Kurth, T., & Eikermann, M. (2017) · BMJ · doi:10.1136/bmj.i6635 · Cited by 65
Timing of vasoactive agents and corticosteroid initiation in septic shock
Ammar, M. A., Ammar, A. A., Wieruszewski, P. M., Bissell, B. D., Long, M. T., Albert, L., Khanna, A. K., & Sacha, G. L. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01021-9 · Cited by 72
Vasopressin for Refractory Hypotension in Extremely Low Birth Weight Infants
Bidegain, M., Greenberg, R. G., Simmons, C., Dang, C., Cotten, C. M., & Smith, P. B. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.04.038 · Cited by 65
Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials
Belletti, A., Musu, M., Silvetti, S., Saleh, O., Pasin, L., Monaco, F., Hajjar, L. A., Fominskiy, E. V., Finco, G., Zangrillo, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142605 · Cited by 65
Renal Medullary Hypoxia: A New Therapeutic Target for Septic Acute Kidney Injury?
Lankadeva, Y. R., Okazaki, N., Evans, R. G., Bellomo, R., & May, C. N. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.10.004 · Cited by 65
Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial
Simon, F., Giudici, R., Scheuerle, A., Gröger, M., Asfar, P., Vogt, J. A., Wachter, U. A., Ploner, F., Georgieff, M., Mӧller, P., et al. (2009) · Critical Care · doi:10.1186/cc7959 · Cited by 64
Management of the postoperative pediatric cardiac surgical patient
Bronicki, R. A., & Chang, A. C. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821b82a6 · Cited by 65
Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial
Endo, A., Yamakawa, K., Tagami, T., Umemura, Y., Wada, T., Yamamoto, R., Nagasawa, H., Takayama, W., Yagi, M., Takahashi, K., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-07910-4 · Cited by 66
Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host‐directed therapies
Lyle, N. H., Pena, O. M., Boyd, J. H., & Hancock, R. E. W. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12444 · Cited by 63
Mechanisms of Vascular Hyporesponsiveness in Septic Shock
Kimmoun, A., Ducrocq, N., & Lévy, B. (2013) · Current Vascular Pharmacology · doi:10.2174/1570161111311020004 · Cited by 65
Cerebral Blood Flow Autoregulation in Sepsis for the Intensivist: Why Its Monitoring May Be the Future of Individualized Care
Goodson, C. M., Rosenblatt, K. R., Rivera‐Lara, L., Nyquist, P., & Hogue, C. W. J. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616673973 · Cited by 63
The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience*
Russell, J. A., Lee, T., Singer, J., Boyd, J. H., & Walley, K. R. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002323 · Cited by 62
Self-citation
Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
Mehta, S., Granton, J. T., Gordon, A. C., Cook, D. J., Lapinsky, S. E., Newton, G. E., Bandayrel, K., Little, A., Siau, C., Ayers, D., et al. (2013) · Critical Care · doi:10.1186/cc12789 · Cited by 62
Self-citation
Development and performance of a novel vasopressor-driven mortality prediction model in septic shock
Vallabhajosyula, S., Jentzer, J. C., Kotecha, A. A., Murphree, D. H., Barreto, E. F., Khanna, A. K., & Iyer, V. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0459-6 · Cited by 62
Renin Kinetics Are Superior to Lactate Kinetics for Predicting In-Hospital Mortality in Hypotensive Critically Ill Patients*
Jeyaraju, M., McCurdy, M. T., Levine, A. R., Devarajan, P., Mazzeffi, M. A., Mullins, K. E., Reif, M., Yim, D. N., Parrino, C. R., Lankford, A. S., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005143 · Cited by 62
The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders
Marsault, É., Llorens‐Cortés, C., Iturrioz, X., Chun, H. J., Lesur, O., Oudit, G. Y., & Auger‐Messier, M. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14123 · Cited by 60
The ADRENAL study protocol: ADjunctive corticosteroid tREatment iN criticAlly ilL patients with septic shock
Venkatesh, B., Myburgh, J., Finfer, S. R., Webb, S. A. R., Cohen, J., Bellomo, R., McArthur, C. J., Joyce, C., Rajbhandari, D., Glass, P., et al. (2013) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01786-6 · Cited by 60
The Surviving Sepsis Campaign Guidelines 2012: Update for Emergency Physicians
Jones, A. E., & Puskarich, M. A. (2013) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2013.08.004 · Cited by 61
Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology
Penack, O., Buchheidt, D., Christopeit, M., von Lilienfeld‐Toal, M., Massenkeil, G., Hentrich, M., Salwender, H. J., Wolf, H., & Ostermann, H. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq442 · Cited by 61
How Outcomes Are Defined in Clinical Trials of Mechanically Ventilated Adults and Children
Blackwood, B., Clarke, M. J., McAuley, D. F., McGuigan, P. J., Marshall, J. C., & Rose, L. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1645pp · Cited by 61
Angiotensin in Critical Care
Hall, A., Busse, L. W., & Ostermann, M. (2018) · Critical Care · doi:10.1186/s13054-018-1995-z · Cited by 60
Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials
Russell, J. A., Lee, T., Singer, J., Backer, D. D., & Annane, D. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.05.003 · Cited by 59
Self-citation
The challenge of evidence in clinical medicine
Tonelli, M. R. (2010) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01405.x · Cited by 58
Norepinephrine in septic shock: when and how much?
Hamzaoui, O., Scheeren, T., & Teboul, J. (2017) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000418 · Cited by 60
Septic Shock — Vasopressin, Norepinephrine, and Urgency
Parrillo, J. E. (2008) · New England Journal of Medicine · doi:10.1056/nejme0800245 · Cited by 57
Medical Therapy of Cardiogenic Shock: Contemporary Use of Inotropes and Vasopressors
Riccardi, M., Pagnesi, M., Chioncel, O. D., Mebazaa, A., Cotter, G., Gustafsson, F., Tomasoni, D., Latronico, N., Adamo, M., & Metra, M. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3162 · Cited by 58
Serious Adverse Events Associated With Vasopressin and Norepinephrine Infusion in Septic Shock*
Anantasit, N., Boyd, J. H., Walley, K. R., & Russell, J. A. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000333 · Cited by 57
Self-citation
Copeptin concentration in cord blood in infants with early-onset sepsis, chorioamnionitis and perinatal asphyxia
Schlapbach, L. J., Frey, S., Bigler, S., Manh-Nhi, C., Aebi, C., Nelle, M., & Nuoffer, J. (2011) · BMC Pediatrics · doi:10.1186/1471-2431-11-38 · Cited by 57
Midodrine for the weaning of vasopressor infusions
Poveromo, L. B., Michalets, E. L., & Sutherland, S. E. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12375 · Cited by 57
Increased Ratio of Visceral to Subcutaneous Adipose Tissue in Septic Patients Is Associated With Adverse Outcome*
Pisitsak, C., Lee, J. G. H., Boyd, J. H., Coxson, H. O., Russell, J. A., & Walley, K. R. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001870 · Cited by 56
Self-citation
Sepsis: An Update on Current Practices in Diagnosis and Management
Jain, S. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.06.012 · Cited by 56
Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial*
Hajjar, L. A., Zambolim, C. M., Belletti, A., de Almeida, J. P., Gordon, A. C., Oliveira, G., Park, C. H. L., Fukushima, J. T., Rizk, S. I., Szeles, T. F., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004023 · Cited by 63
Self-citation
Machine learning models with preoperative risk factors and intraoperative hypotension parameters predict mortality after cardiac surgery
Fernandes, M. P. B., Armengol de la Hoz, M., Rangasamy, V., & Subramaniam, B. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.07.029 · Cited by 53
Vasopressors in septic shock: a systematic review and network meta-analysis
Zhou, F., Mao, Z., Zeng, X., Kang, H., Liu, H., Pan, L., & Hou, P. C. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s80060 · Cited by 58

Authors: Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., Cook, D. J., Presneill, J. J., & Ayers, D.
Affiliations: St. Paul's Hospital (CA)
University of Ottawa (CA)
The Alfred Hospital (AU)
University of British Columbia (CA)
Mount Sinai Hospital (CA)
University of Toronto (CA)
McMaster University (CA)
The Royal Melbourne Hospital (AU)
ORCID: Russell, James A.
Walley, Keith R.
Singer, Joel
Gordon, Anthony C.
Hébert, Paul C.
Cooper, D. James
Holmes, Cheryl L.
Mehta, Sangeeta
Granton, John T.
Presneill, Jeffrey J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2008-02-28
Volume: 358
Issue: 9
Pages: 877-887
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa067373
OpenAlex: W2108153775
Cited by: 1,924
References: 36
Citations by year: 2026: 106 · 2025: 119 · 2024: 101 · 2023: 91 · 2022: 88 · 2021: 85 · 2020: 104 · 2019: 205 · 2018: 114 · 2017: 104 · 2016: 100 · 2015: 83 · 2014: 91 · 2013: 84 · 2012: 89
FWCI: 88.86
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
Keywords: septic shock, vasopressin, norepinephrine, vasopressor therapy, catecholamines, mortality, 28-day mortality, 90-day mortality, sepsis treatment, blood pressure support, adverse events, subgroup analysis
MeSH terms: Adult, Aged, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Infusions, Intravenous, Male, Middle Aged, Norepinephrine, Severity of Illness Index, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Failure, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks